pharma news today glp-1 Giants Bet on Next-Generation Treatments to Sustain Growth The expanding landscape of GLP-1
Description
Kind Patches told TODAY.com that the name change to "Berberine Patches" was made because it "is better appreciated by our customers, as it more clearly states the main ingredient." The company added: "We are not a pharmaceutical company and we do not make any medical claims." What do the reviews actually say
My brains working better
This distinction matters enormously right now, and patients need to understand it
Occasional choices outside this framework are unlikely to derail progress
Setting: OneFlorida+ network, consisting of 14 health systems, and ~20 million patients from 20142024
